Extracorporeal Organ Support
- 26 September 2017
- journal article
- viewpoint
- Published by American Medical Association (AMA) in JAMA
- Vol. 318 (12), 1105-1106
- https://doi.org/10.1001/jama.2017.10108
Abstract
Mechanical ventilation, renal replacement therapy, and artificial liver detoxification circuits are among the systems designed to support or replace organs compromised by trauma, sepsis, or acute respiratory, kidney, or liver failure. Among these systems, extracorporeal membrane oxygenation (ECMO) has recently generated increasing expectations despite results from early clinical trials in adults that suggested ECMO use should be restricted to only those patients determined by specialized clinicians to have a very high risk of mortality.This publication has 6 references indexed in Scilit:
- Efficacy and Economic Assessment of Conventional Ventilatory Support versus Extracorporeal Membrane Oxygenation for Severe Adult Respiratory Failure (CESAR)Published by Oxford University Press (OUP) ,2018
- Part 6: Alternative Techniques and Ancillary Devices for Cardiopulmonary ResuscitationJournal of the American College of Cardiology, 2015
- Extracorporeal Membrane Oxygenation for Pandemic Influenza A(H1N1)–induced Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009The New England Journal of Medicine, 2009
- Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress SyndromeJAMA, 2009
- Poly-Methyl Pentene Oxygenators Have Improved Gas Exchange Capability and Reduced Transfusion Requirements in Adult Extracorporeal Membrane OxygenationASAIO Journal, 2005